Lest we forget Hansen's disease (leprosy): An unusual presentation with an acute onset of inflammatory polyarthritis and the rheumatology experience

International Journal of Rheumatic Diseases

Volumn 12, Issue 1, 2009, Pages 64-69

  Sheetal, Salvi ^a   Arvind, Chopra ^a  

^a Center for Rheumatic Diseases   (India)

Author keywords

Arthritis; Leprosy; Polyarthritis; Tropical arthritis; Type I leprosy reaction

Indexed keywords

ANALGESIC AGENT; ANTIINFLAMMATORY AGENT; C REACTIVE PROTEIN; CLOFAZIMINE; DAPSONE; HEMOGLOBIN; NONSTEROID ANTIINFLAMMATORY AGENT; RHEUMATOID FACTOR; RIFAMPICIN; STEROID;

ADULT; ANKLE; ANKLE EDEMA; ARTHRALGIA; ARTICLE; BACILLUS; BACTERIUM DETECTION; CASE REPORT; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DRUG RESPONSE; ERYTHEMA; ERYTHROCYTE SEDIMENTATION RATE; FOLLOW UP; GAIT DISORDER; HAND JOINT; HAND RADIOGRAPHY; HEMOGLOBIN BLOOD LEVEL; HUMAN; JOINT SWELLING; LEPROMATOUS LEPROSY; MALE; OSTEOPOROSIS; PAIN ASSESSMENT; PATIENT REFERRAL; POLYARTHRITIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PRURITUS; RASH; RHEUMATOID ARTHRITIS; SENSORY DYSFUNCTION; ULCER HEALING; VISUAL ANALOG SCALE;

ACUTE DISEASE; AGED; ARTHRITIS; CLOFAZIMINE; DAPSONE; DIAGNOSIS, DIFFERENTIAL; DRUG THERAPY, COMBINATION; EXANTHEMA; GLUCOCORTICOIDS; HUMANS; LEPROSTATIC AGENTS; LEPROSY; MALE; MIDDLE AGED; MYCOBACTERIUM LEPRAE; PERIPHERAL NERVES; PERIPHERAL NERVOUS SYSTEM DISEASES; RIFAMPIN; TREATMENT OUTCOME;

EID: 63849323133     PISSN: 17561841     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1756-185X.2009.01382.x     Document Type: Article

References (18)

1. Gelber RH (2001) Leprosy (Hansen's Disease). In: Braunwald E, Hauser SL, Fauci AS, Longo DL, Kasper DL, Jameson JL (eds) Harrison's Principles of Internal Medicine, pp. 1035-40. Mcgraw -Hill, New Delhi.
2. Samant R, Nadkar MY, Vaidya SS, Chhugani SJ, Balaji R, Borges NE (1999) Leprosy: A close mimic in a rheumatology clinic. J Assoc Physicians India 47, 576-9.
3. Agarwal V, Wakhlu A, Agarwal A, Mishra R (2002) Tenosynovitis as the presenting manifestation of Leprosy. J Indian Rheumatol Assoc 10, 69-70.
4. Agarwal V, Singh R, Chauhan S, Sachdev A, Mohan H (2004) Pitting oedema with arthritis as the presenting manifestation of Type I Lepra Reaction. J Indian Rheumatol Assoc 12, 123-6.
5. Haneen AA, Uppal SS, Rana AR, Ibrahim L (2005) First report of leprosy presenting as acute polyarthritis in the setting of Type I downgrading Lepra Reaction. Clin Rheumatol 25, 101-5.
6. Haroon N, Agarwal V, Agarwal A, Kumari N, Krishnani N, Mishra R (2007) Arthritis as presenting manifestation of pure neuritic leprosy- a rheumatologist dilemma. Rheumatology 46, 653-6.
7. Yens DA, Asters Dimitrios J, Teital Ariel (2003) Subcutaneous Nodules and joint Deformity in Leprosy. J Clin Rheumatol 9, 181-6.
8. Gibson T, Ahsan Q, Hussein K (1994) Arthritis of Leprosy. Br J Rheumatol 33, 963-6.
9. Vengadakrishnan K, Saraswat Pradeep K, Mathur PC (2004) A study of rheumatological manifestations of leprosy. Indian J Dermatol Venerol Leprol 70, 70-8.
10. Rothschild BM, Behnam S (2005) The often overlooked digital tuft: Clues to diagnosis and pathology of neuropathic disease and Spondyloarthopathy. Ann Rheum Dis 64, 286-90.
11. Atkin SL, Welbury RR, Stanfield E, Beavis D, Iwais B, Dick WC (1987) Clinical and laboratory studies of inflammatory polyarthritis in patients with leprosy in Papua New Guinea. Ann Rheum Dis 46, 688-90.
12. Claudia Andrea Helling, Ana Locursio Maria Elena Manzur Maria Leticia Sormani de Fonseca (2005) Remmiting seronegative symmetrical synovitis with pitting edema in Leprosy. Clin Rheumatol 25, 95-7.
13. http://www.whoindia.org/EN/Section3/Section122_652.htm. Core Programme Clusters. Leprosy (Leprosy Situation in India) Dt 05/01/2008.
14. WHO Expert Committee on Leprosy (1998) Seventh Report. WHO Technical Report Series no. 874. World Health Organization, Geneva.
15. Chopra A, Patil J, Billampelly V, Relwani J, Tandale HS (2001) Prevalence of Rheumatic diseases in a rural population in Western India: a WHO-ILAR COPCORD Study. J Assoc Physicians India 49, 240-6.
16. Sugata Y, Miyamoto M, Koseki M, Ishi N, Nakajima H (1997) Suppression of tumor necrosis factor-α expressions in leprosy in skin lesions during treatment for leprosy. Br J Dermatol 136, 393-7.
17. Chopra A, Lagoo-Joshi V, Kunjeer V (2006) Our experience with anti-TNF therapy - a choice between the devil and the deep sea. APLAR J Rheumatol 9, A208.
18. Patrtna M, Shekhar P, Sudeshna M, Surjit B, Bibhuti S (2006) Boderline Tuberculoid Leprosy. A manifestation of immune reconstitution inflammatory syndrome in a human immunomodulatory virus infected person. Indian J Dermatol 51, 278-80.